DE4143214A1 - Synergistisch wirkende antikoerperzusammensetzung - Google Patents
Synergistisch wirkende antikoerperzusammensetzungInfo
- Publication number
- DE4143214A1 DE4143214A1 DE4143214A DE4143214A DE4143214A1 DE 4143214 A1 DE4143214 A1 DE 4143214A1 DE 4143214 A DE4143214 A DE 4143214A DE 4143214 A DE4143214 A DE 4143214A DE 4143214 A1 DE4143214 A1 DE 4143214A1
- Authority
- DE
- Germany
- Prior art keywords
- antibody
- antibodies
- molar ratio
- seq
- il2rα
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4143214A DE4143214A1 (de) | 1991-07-25 | 1991-12-30 | Synergistisch wirkende antikoerperzusammensetzung |
IE202892A IE922028A1 (en) | 1991-07-25 | 1992-07-01 | Antibody composition acting synergistically |
IL102562A IL102562A0 (en) | 1991-07-25 | 1992-07-20 | Antibody composition acting synergistically |
AU23788/92A AU2378892A (en) | 1991-07-25 | 1992-07-23 | Synergistic antibody composition |
PCT/EP1992/001689 WO1993001834A1 (fr) | 1991-07-25 | 1992-07-23 | Composition d'anticorps a effet synergique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4124759 | 1991-07-25 | ||
DE4143214A DE4143214A1 (de) | 1991-07-25 | 1991-12-30 | Synergistisch wirkende antikoerperzusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
DE4143214A1 true DE4143214A1 (de) | 1993-01-28 |
Family
ID=25905832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE4143214A Withdrawn DE4143214A1 (de) | 1991-07-25 | 1991-12-30 | Synergistisch wirkende antikoerperzusammensetzung |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU2378892A (fr) |
DE (1) | DE4143214A1 (fr) |
IE (1) | IE922028A1 (fr) |
IL (1) | IL102562A0 (fr) |
WO (1) | WO1993001834A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1615664A1 (fr) * | 2004-02-18 | 2006-01-18 | Medexgen Inc. | Composition pharmaceutique utile dans le traitement de troubles immunologiques |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8605316D0 (en) * | 1986-03-04 | 1986-04-09 | Royal Free Hosp School Med | Immunosuppression |
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
FR2616330B1 (fr) * | 1987-06-12 | 1990-12-21 | Immunotech Sa | Agent actif et medicament en contenant destines a prevenir ou a combattre le rejet de greffe d'organe chez l'homme |
DE4028955A1 (de) * | 1990-09-12 | 1992-03-19 | Boehringer Mannheim Gmbh | Monoklonale antikoerper gegen den interleukin 2-rezeptor |
-
1991
- 1991-12-30 DE DE4143214A patent/DE4143214A1/de not_active Withdrawn
-
1992
- 1992-07-01 IE IE202892A patent/IE922028A1/en not_active Application Discontinuation
- 1992-07-20 IL IL102562A patent/IL102562A0/xx unknown
- 1992-07-23 WO PCT/EP1992/001689 patent/WO1993001834A1/fr active Application Filing
- 1992-07-23 AU AU23788/92A patent/AU2378892A/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1615664A1 (fr) * | 2004-02-18 | 2006-01-18 | Medexgen Inc. | Composition pharmaceutique utile dans le traitement de troubles immunologiques |
EP1615664A4 (fr) * | 2004-02-18 | 2006-12-27 | Medexgen Inc | Composition pharmaceutique utile dans le traitement de troubles immunologiques |
Also Published As
Publication number | Publication date |
---|---|
IL102562A0 (en) | 1993-01-14 |
AU2378892A (en) | 1993-02-23 |
WO1993001834A1 (fr) | 1993-02-04 |
IE922028A1 (en) | 1993-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69916807T2 (de) | Kostimulatorische blockade und gemischter chimerismus in allotransplantationen | |
DE69433820T2 (de) | Verwendung von löslichen oligomerischen cd40 liganden oder monoklonalen antikörpern zur herstellung eines arzneimitells zur vorbeugung oder behandlung von neoplastischen krankheiten | |
DE69723888T2 (de) | Gemischter Chimerismus und Toleranz | |
DE69733960T2 (de) | Verwendung von Antikörpern gegen CD45RO Leukozytenantigen zur Immunmodulation | |
DE69713499T3 (de) | Verfahren zur inhibierung der immunreaktion durch blockierung der gp39/cd40 und ctla4/cd28/b7 routen und zusammensetzung zu deren verwendung | |
EP0453898B1 (fr) | Utilisation d'anticorps contre le facteur de nécrose tumorale (TNF) comme médicament pour le traitement d'ischémies et de leurs conséquences | |
DE69533189T2 (de) | Immuntherapie von krebs mit allogenen lymphocyten | |
DE69533331T2 (de) | Liganden zur induktion der antigen-spezifischen apoptose in t-zellen | |
EP1115427B1 (fr) | Utilisation de cellules tumorales avec un decalage temporel en combinaison avec des anticorps intacts pour l'immunisation | |
DE69535713T2 (de) | Verfahren zur modulierung von t-zellreaktionen durch manipulation einer gemeinsamen zytokinrezeptor-gammakette | |
DD296843A5 (de) | Monoklonale antikoerper zur indukzierung von tobranz | |
EP1600164A2 (fr) | Utilisation d'une substance liant le CD28 dans la production d'une composition pharmaceutique à effet dose-dépendant | |
EP1200126B1 (fr) | Utilisation d'anticorps monoclonaux specifiques de cd28 pour preparer une composition pharmaceutique appropriee au traitement d'infections virales | |
EP0340604B1 (fr) | Anticorps monoclonal et son utilisation | |
EP0802924B1 (fr) | Medicament pour l'immunosuppression et elimination des cellules tumeureuses prolongee | |
DE60220894T2 (de) | Verwendung von interleukin-12 zur behandlung von nervenschäden | |
DE10050935A1 (de) | Verwendung CD28 spezifischer monoklonaler Antikörper zur Stimulation von Blutzellen, welche kein CD28 tragen | |
WO2004056873A1 (fr) | Accroissement de la reponse immunitaire par des substances qui influencent la fonction de cellules k naturelles | |
DE69815840T2 (de) | Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren | |
DE3818054C2 (de) | Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen | |
DE69531166T2 (de) | Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen | |
DE69737888T2 (de) | Anti-mhc klasse ii bindungsreagentien zur verwendung bei xenotransplantationen | |
DE4143214A1 (de) | Synergistisch wirkende antikoerperzusammensetzung | |
DE69728654T2 (de) | Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus | |
US8277811B2 (en) | Compositions and methods for inducing chimerism in a subject |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |